Deccan Gold Mines Ltd ₹80.00· 150 : 601· Open
Natco Pharma Ltd ₹750.00· 2 : 21· Open
Ola Electric Mobility ₹27.00· 2 : 25· Upcoming
Deccan Gold Mines Ltd ₹80.00· 150 : 601· Open
Natco Pharma Ltd ₹750.00· 2 : 21· Open
Ola Electric Mobility ₹27.00· 2 : 25· Upcoming

Natco Pharma Ltd Right Issue

₹1,279.36 Cr BSE, NSE 16 Oct 2026 – 22 Oct 2026

Open Ratio: 2 : 21 BSE, NSE
Home › Right Issue › Natco Pharma Ltd
← Back to List
Issue Price
₹750.00
Face Value
₹2.00
Issue Size (Shares)
17,058,082
Issue Size (₹ Cr.)
₹1,279.36
Current Market Price
📅 Right Issue Timetable
Last Date to Buy SharesWed, Sep 30, 2026
Record DateThu, Oct 1, 2026
Credit of Rights EntitlementsTue, Oct 6, 2026
Bid/Offer Opens OnMon, Oct 12, 2026
Issue Open DateFri, Oct 16, 2026
Renunciation Last DateFri, Oct 16, 2026
Bid/Offer Closes OnThu, Oct 22, 2026
Issue Close DateThu, Oct 22, 2026
Deemed Date of AllotmentFri, Oct 23, 2026
Credit DateMon, Oct 26, 2026
Listing DateTue, Oct 27, 2026
📋 Right Issue Details
Issue Size (Shares)17,058,082
Issue Size (Amount)₹1,279.36 Cr.
Issue Price₹750.00 per share
Face Value₹2.00 per share
Entitlement Ratio2 : 21
Listing AtBSE, NSE
Terms of Payment₹750 per share payable in full at the time of application.
📊 Company Financials (Restated)
Period Ended26-06-3026-03-312025-03-31
Income794.404,375.904,784.00
EBITDA———
Net Worth9,538.509,221.107,607.00
Reserves & Surplus9,502.709,185.307,571.20

Amount in ₹ Crore

🎯 Objects of the Issue
#ObjectEst. Amount (₹ Crores)
1Pre-payment or repayment of all or a portion of certain outstanding borrowings availed by the Company₹810.50
2Funding a portion of the expenditure towards research and development initiatives of the Company, including funding costs of employees in our research and development team₹110.00
3General Corporate Purposes₹338.50
Total₹1,259.00
🏢 About the Company
Incorporated in 1981, NATCO Pharma Limited is a pharmaceutical company engaged in the research, development, manufacturing and marketing of niche and complex pharmaceutical products across domestic and international markets. The Company operates across pharmaceuticals and Crop Health Sciences, with a focus on developing affordable and differentiated healthcare solutions.

The Company's pharmaceutical business includes Finished Dosage Formulations (FDFs) and Active Pharmaceutical Ingredients (APIs) across therapeutic areas such as oncology, gastroenterology and hepatology, neurology, infectious diseases, cardiology and diabetology. Its API business focuses on complex chemistries and specialty products, with oncology as a key area. NATCO has developed more than 75 APIs and has over three decades of experience in API development and commercialization.

NATCO also operates its Crop Health Sciences business, offering agrochemical products including insecticides, fungicides, herbicides and plant growth promoters. The Company has introduced Chlorantraniliprole-based products and pheromone-based pest management solutions, with a focus on environmentally conscious crop protection and green chemistry.

The Company has manufacturing facilities for formulations, APIs and crop health sciences, along with dedicated research and development centres. Its facilities are located across Telangana, Andhra Pradesh, Uttarakhand, Assam and Tamil Nadu and have approvals from various global regulatory authorities. NATCO markets and distributes its products in over 50 countries, including the United States, India, Canada and Brazil.
📞 Company Contact
CompanyNatco Pharma Ltd
Address‘NATCO House"
Road No. 2
Banjara Hills
Hyderabad, 500034
Phone914023547532
Emailinvestors@natcopharma.co.in
WebsiteVisit ↗
📝 Registrar
NameKfin Technologies Ltd
Phone040-79615565
Emailnatcopharma.rights@kfintech.com
WebsiteVisit ↗
📊 Subscription Status
Day Total Shares Bid Subscription (Times) Updated At
1,370,475 0.08x 13 Oct 2026, 06:40 PM
Day 1 1,298,321 0.08x 16 Oct 2026, 11:50 PM
Day 2 2,264,019 0.13x 16 Oct 2026, 11:50 PM
Day 3 3,735,327 0.22x 16 Oct 2026, 11:50 PM
Day 4 3,895,308 0.23x 16 Oct 2026, 11:50 PM
Day 5 4,440,287 0.26x 16 Oct 2026, 11:50 PM
Latest (Day 5) 4,440,287 0.26x 16 Oct 2026